These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
438 related articles for article (PubMed ID: 23450334)
21. Trends in antipsychotic prescribing in schizophrenia in Auckland. Wheeler A; Humberstone V; Robinson G Australas Psychiatry; 2006 Jun; 14(2):169-74. PubMed ID: 16734645 [TBL] [Abstract][Full Text] [Related]
22. Comparative Effectiveness of Clozapine and Standard Antipsychotic Treatment in Adults With Schizophrenia. Stroup TS; Gerhard T; Crystal S; Huang C; Olfson M Am J Psychiatry; 2016 Feb; 173(2):166-73. PubMed ID: 26541815 [TBL] [Abstract][Full Text] [Related]
23. Antipsychotic polypharmacy and quality of life in patients with schizophrenia treated in primary care in China. Hou CL; Ma XR; Zang Y; Jia FJ; Lin YQ; Chiu HF; Ungvari GS; Ng CH; Zhong BL; Cao XL; Li Y; Cai MY; Xiang YT Int J Clin Pharmacol Ther; 2016 Jan; 54(1):36-42. PubMed ID: 26521927 [TBL] [Abstract][Full Text] [Related]
24. Assessment of inpatient psychiatric readmission risk among patients discharged on an antipsychotic polypharmacy regimen: A retrospective cohort study. Boskailo E; Malkoc A; McCurry DB; Venter J; Drachman D; Ramos GM Acta Med Acad; 2017 Nov; 46(2):133-144. PubMed ID: 29338277 [TBL] [Abstract][Full Text] [Related]
25. Antipsychotic polypharmacy and augmentation strategies prior to clozapine initiation: a historical cohort study of 310 adults with treatment-resistant schizophrenic disorders. Thompson JV; Clark JM; Legge SE; Kadra G; Downs J; Walters JT; Hamshere ML; Hayes RD; Taylor D; MacCabe JH J Psychopharmacol; 2016 May; 30(5):436-43. PubMed ID: 26905920 [TBL] [Abstract][Full Text] [Related]
26. Antipsychotic prescribing and its correlates in New Zealand. Dey S; Menkes DB; Obertova Z; Chaudhuri S; Mellsop G Australas Psychiatry; 2016 Aug; 24(4):360-4. PubMed ID: 26819405 [TBL] [Abstract][Full Text] [Related]
27. Patterns and trends in antipsychotic prescribing for Parkinson disease psychosis. Weintraub D; Chen P; Ignacio RV; Mamikonyan E; Kales HC Arch Neurol; 2011 Jul; 68(7):899-904. PubMed ID: 21747029 [TBL] [Abstract][Full Text] [Related]
28. Prevalence and nature of antipsychotic polypharmacy among inpatients with schizophrenia spectrum disorders at an Australian mental health service. John AP; Gee T; Alexander S; Ramankutty P; Dragovic M Australas Psychiatry; 2014 Dec; 22(6):546-50. PubMed ID: 25147317 [TBL] [Abstract][Full Text] [Related]
30. Clozapine utilization at the United States Veterans Health Administration: a descriptive report of prescribing patterns and patient characteristics among Operation Enduring Freedom/Operation Iraqi Freedom Veterans. Zuschlag ZD; Fowler CA; Devendorf A; Panaite V; Efimova O; Schultz SK Int Clin Psychopharmacol; 2020 Nov; 35(6):322-328. PubMed ID: 32815822 [TBL] [Abstract][Full Text] [Related]
31. Real-world effectiveness of antipsychotic monotherapy vs. polypharmacy in schizophrenia: to switch or to combine? A nationwide study in Hungary. Katona L; Czobor P; Bitter I Schizophr Res; 2014 Jan; 152(1):246-54. PubMed ID: 24275583 [TBL] [Abstract][Full Text] [Related]
32. Long-term combination antipsychotic treatment in VA patients with schizophrenia. Kreyenbuhl J; Valenstein M; McCarthy JF; Ganoczy D; Blow FC Schizophr Res; 2006 May; 84(1):90-9. PubMed ID: 16631354 [TBL] [Abstract][Full Text] [Related]
33. Critical review of antipsychotic polypharmacy in the treatment of schizophrenia. Fleischhacker WW; Uchida H Int J Neuropsychopharmacol; 2014 Jul; 17(7):1083-93. PubMed ID: 22717078 [TBL] [Abstract][Full Text] [Related]
34. Clozapine users in Australia: their characteristics and experiences of care based on data from the 2010 National Survey of High Impact Psychosis. Siskind DJ; Harris M; Phillipou A; Morgan VA; Waterreus A; Galletly C; Carr VJ; Harvey C; Castle D Epidemiol Psychiatr Sci; 2017 Jun; 26(3):325-337. PubMed ID: 27426892 [TBL] [Abstract][Full Text] [Related]
35. Antipsychotic prescribing before clozapine in a community psychiatric hospital: a case note review. Najim H; Heath D; Singh P Psychiatr Danub; 2013 Sep; 25 Suppl 2():S165-70. PubMed ID: 23995168 [TBL] [Abstract][Full Text] [Related]
36. Evaluation of Concurrent Oral and Long-Acting Injectable Antipsychotic Prescribing at the Minneapolis Veterans Affairs Health Care System. Dimitropoulos E; Drogemuller L; Wong K J Clin Psychopharmacol; 2017 Oct; 37(5):605-608. PubMed ID: 28816923 [TBL] [Abstract][Full Text] [Related]
37. Underprescribing of clozapine and unexplained variation in use across hospitals and regions in the Canadian province of Québec. Latimer E; Wynant W; Clark R; Malla A; Moodie E; Tamblyn R; Naidu A Clin Schizophr Relat Psychoses; 2013 Apr; 7(1):33-41. PubMed ID: 23367500 [TBL] [Abstract][Full Text] [Related]
38. Antipsychotic polypharmacy and high-dose prescription in schizophrenia: a 5-year comparison. Roh D; Chang JG; Kim CH; Cho HS; An SK; Jung YC Aust N Z J Psychiatry; 2014 Jan; 48(1):52-60. PubMed ID: 23671214 [TBL] [Abstract][Full Text] [Related]
39. [Use of atypical antipsychotics in Charles Perrens psychiatric hospital (Bordeaux) analysis of prescribing practices for Amisulpride, Clozapine, Olanzapine and Risperidone]. Bret P; Bonnet F; Bret MC; Jaffré A Encephale; 2002; 28(4):329-42. PubMed ID: 12232542 [TBL] [Abstract][Full Text] [Related]
40. The hidden magnitude of polypharmacy: using defined daily doses and maximum licensed daily doses to measure antipsychotic load. Nguyen ML; Sunderland B; Lim S; Hattingh L; Chalmers L Int J Clin Pharm; 2019 Dec; 41(6):1642-1651. PubMed ID: 31677120 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]